Russell Schilder, MD
Enriched profileEmeritus Faculty, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University · Thomas Jefferson University
Russell Schilder is Emeritus Faculty, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University at Thomas Jefferson University. ClinicalTrials.gov lists 15 registered studies with this person as an investigator.
Data verified 17 Aug 2026
Overview
Updated 2 Sept 2026
Russell J. Schilder, M.D., is Emeritus Faculty, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University. The public record shows 209 publications with 11,810 citations (h-index 52), centered on Ovarian / Gynecologic Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 11 companies, 3 NIH-funded awards (1992–2024).
- Top research focus: Ovarian / Gynecologic Cancer
- 15 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 2 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 2 Sept 2026
Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:
- Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Sponsor: Gynecologic Oncology Group
Industry payments
Updated 2 Sept 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year20259 payments$34,000openpaymentsdata.cms.gov ↗
- Ipsen InnovationProgram year20251 payment
- Baxter HealthcareProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Opioid Agonist100%Morphine Sulfate Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 2 Sept 2026
3 NIH research awards on record, funded 1992–2024 per NIH RePORTER. The latest:
- Sidney Kimmel Cancer Center LAPS Institutional Collaboration
Thomas Jefferson University
FY2024$543,697UG1CA233341 - Sidney Kimmel Cancer Center LAPS Institutional Collaboration
Thomas Jefferson University
FY2023$398,464UG1CA233341 - Sidney Kimmel Cancer Center LAPS Institutional Collaboration
Thomas Jefferson University
FY2022$398,464UG1CA233341
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Online presence
Updated 2 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
contexttherapeutics.com/team-bios/karenandreas-3alcy-yt3a9
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →contexttherapeutics.com ↗ - Other
onclive.com/authors/russell-j-schilder-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 2 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗
- Board Certified
Medical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗ - Board Certified
Hematology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗ - Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗ - M.S.
University of Miami
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →contexttherapeutics.com ↗
Editorial & leadership roles
journal and society appointments- Chair
NRG Oncology Developmental Therapeutics Gynecologic Cancer Phase I Subcommittee (former)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →contexttherapeutics.com ↗ - Steering Committee Member
NCI CTEP Gynecologic Cancer
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →contexttherapeutics.com ↗ - Chair
ECOG/ACRIN Gynecologic Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →contexttherapeutics.com ↗
Awards & honors
honors on the public record- Achievement in Clinical Research Award
Sidney Kimmel Cancer Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jeffersonhealth.org ↗
Secondary affiliations
appointments beyond the home institution- Consulting Medical Director
Context Therapeutics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →contexttherapeutics.com ↗ - Former Professor
Department of Medical Oncology and Chief of Gynecologic Medical Oncology, Fox Chase Cancer Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →contexttherapeutics.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Carol Shields, MD
Thomas Jefferson University
Joseph Bavaria, MD
Thomas Jefferson University
Michele Meltzer, MD
Thomas Jefferson University
Marinos Dalakas, MD
Thomas Jefferson University